A pivotal clinical trial of the two DTx – including CT-155 – started ... Called CONVOKE, the 16-week study is enrolling a target of 432 patients, with results due in the middle of 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback